#SOPH

@voiceofchain.bsky.social

2 days ago

SOPH price chart

📊 $SOPH 51.5x vol

$SOPH VOLUME: 51.5x spike, 1 exchange.
Cautious note: liquidity on that single venue can shift quickly.
Trade small, set tight stops.
#SOPH #crypto #bitcoin #finbsky #orderflow #liquidation
🔗 https://voiceofchain.com/event/vol_SOPH_20260406_085840

1 0 1 0

VoiceOfChain

@voiceofchain.bsky.social

2 days ago

SOPH price chart

💰 $SOPH 8.26% arb

8.26% spread: buy OKXS $0.0088, sell Binance $0.0095 💸
$SOPH ARB setup looks solid—keep it tight and chase the quick flip
Watch for slippage, aim for fas...
#SOPH #ethereum #bitcoin #bsky #arbitrage #arb
🔗 voiceofchain.com/event/arb_SOPH_1_2026040...

1 0 2 0

VoiceOfChain

@voiceofchain.bsky.social

1 week ago

SOPH price chart

📊 $SOPH 77.1x vol

[SIGNAL] $SOPH volume spike 77.1x on 1 exchange. Pattern match: 68% probability of continuation. Monitor depth and potential slippage on this thin-book move. ...
#SOPH #ethereum #cryptocurrency #bsky #volume #whale
🔗 https://voiceofchain.com/event/vol_SOPH_20260329_133121

0 0 0 0

VoiceOfChain

@voiceofchain.bsky.social

1 week ago

SOPH price chart

💰 $SOPH 5.32% arb

$SOPH ARB: 5.32% spread, buy BinanceF $0.0084, sell OKX $0.0088. EDGE on this arb, ~0.0004 edge per unit, liquidity decent. Act fast, buying
#SOPH #crypto #btc #finbsky #opportunity #arbitrage
🔗 voiceofchain.com/event/arb_SOPH_2_2026032...

0 0 0 0

Bette Midler: Bootleg Betty

@bootlegbetty.bsky.social

3 weeks ago

Boodles BonBon Video: A Wood Joke From Bette Midler

bootlegbetty.com/2026/03/19/b...

#BetteMidler, #Boodles BonBon, #Ernir, #Soph, #Video, #Wood

To Read The Article, Click The Link Above Or Copy/Paste It In Your Browser!

3 0 0 0

VoiceOfChain

@voiceofchain.bsky.social

3 weeks ago

SOPH price chart

💰 $SOPH ARB 6.33%
🟢 Bitget → 🔴 OKX
#SOPH #arbitrage
🔗 voiceofchain.com/event/arb_SOPH_2_2026031...

0 0 0 0

StockTitan

@stocktitan.net

1 month ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results Revenue was $21.7 million, up 22% year-over-year Gross margin was 67.7% on a reported basis and 73.9% on an adjusted basis, compared to 68.2% reported and 74.2% adjusted in the prior year period IFRS net loss was $19.2 million, an increase of 27% year-over-year; Adjusted EBITDA loss was $9.9 million, an increase of 9% year-over-year. Revenue was $77.3 million, up...

#SOPH SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results

www.stocktitan.net/news/SOPH/sop-hi-a-genet...

0 0 0 0

VoiceOfChain

@voiceofchain.bsky.social

1 month ago

SOPH price chart

💰 $SOPH 4.13% arb

$SOPH ARB: 4.13% spread, buy Bitget at 0.0094, sell OKX at 0.0098. Opportunity noted. Risk: exchange liquidity and withdrawal/transfer delays can erode the arb...
#SOPH #cryptocurrency #btc #bsky #profit #arb
🔗 voiceofchain.com/event/arb_SOPH_2_2026022...

0 0 0 0

VoiceOfChain

@voiceofchain.bsky.social

1 month ago

SOPH price chart

💰 $SOPH 3.84% arb

$SOPH ARB: 3.84% spread, buy Bitunix at 0.0099, sell OKX at 0.0103.
Check fees and liquidity; confirm transfer timing to avoid slippage.
Trade small size...
#SOPH #cryptocurrency #bitcoin #bsky #profit #arb
🔗 voiceofchain.com/event/arb_SOPH_2_2026022...

0 0 0 0

VoiceOfChain

@voiceofchain.bsky.social

1 month ago

SOPH price chart

💰 $SOPH 5.31% arb

5.31% spread on $SOPH ARB: buy Bitunix @ $0.0097, sell OKX @ $0.0102 💸
Arb window looks prime for a quick flip.
Go for tight fills and report b...
#SOPH #cryptocurrency #ethereum #bsky #opportunity #profit
🔗 voiceofchain.com/event/arb_SOPH_2_2026022...

0 0 0 0

VoiceOfChain

@voiceofchain.bsky.social

1 month ago

SOPH price chart

💰 $SOPH 5.02% arb

[SIGNAL] $SOPH ARB: spread 5.02%, buy OKXS at $0.0095, sell OKXS at $0.0099.
Quick-arb setup with 62% probability of capturing the spread within 12 min...
#SOPH #cryptocurrency #btc #finbsky #opportunity #arb
🔗 voiceofchain.com/event/arb_SOPH_1_2026022...

1 0 0 0

StockTitan

@stocktitan.net

2 months ago

AI-driven medicine firm hands CEO job to insider after big 2025 SOPHiA GENETICS posts at least $21M Q4 and ~$77M 2025 revenue, guides 2026 sales to $92-$94M, up 20-22%, and plans to make Ross Muken CEO on July 1, 2026.

#SOPH SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

www.stocktitan.net/news/SOPH/sop-hi-a-genet...

0 0 0 0

Bette Midler: Bootleg Betty

@bootlegbetty.bsky.social

4 months ago

Video: Happy 80th Bette Midler – The Perfect Joke!

#BetteMidler, #depressiontour, #LiveATLast, #Soph, #SophJokes

bootlegbetty.com/2025/12/01/v...

To Read The Article, Click The Link Above Or Copy/Paste It In Your Browser!

5 1 1 0

@fosseeboss.bsky.social

4 months ago

Loyal Gamers + Quads We survived as a society to episode 9.

Best survivor recap of ep 9 you’ll ever read! open.substack.com/pub/thefosso...
#season49 #survivor #soph #jeff

0 0 0 0

Big Brother Brain (Morgan’s M&M’s)

@bigbrotherbrain1.bsky.social

4 months ago

THEY GOT AWAY WITH ALL THREE OF THEIR ADVANTAGES. AGAIN. #Rizzo #SAVANNAH #SOPH. #survivor49

5 1 0 0

StockTitan

@stocktitan.net

4 months ago

#SOPH Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025

www.stocktitan.net/news/SOPH/complete-genom...

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine BOSTON and SAN DIEGO, Nov. 11, 2025/ PRNewswire/-- SOPHiA GENETICS, a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at the Association for Molecular Pathology Annual Meeting a partnership that unites sequencing and AI analytics to...

#SOPH SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

www.stocktitan.net/news/SOPH/sop-hi-a-genet...

0 0 0 0

StockTitan

@stocktitan.net

5 months ago

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance SOPHiA GENETICS (Nasdaq: SOPH) reported Q3 2025 results: revenue $19.5M (+23% YoY), net IFRS loss $20.0M (+9% YoY) and adjusted EBITDA loss $10.2M (+8% YoY). Adjusted gross margin was 73.1% (adjusted basis). Excluding elevated Swiss social charges, adjusted EBITDA loss would have been $8.8M, a 13% YoY improvement.Management raised 2025 revenue guidance to $75–$77M (growth 15–18%) and expects adjusted EBITDA loss of $39–$41M. Q3 operational highlights: 99,000 analyses (+9% YoY), 31 new customers, average contract value of new signings +180% YoY, and U.S. revenue growth of 30% YoY.

#SOPH SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

www.stocktitan.net/news/SOPH/sop-hi-a-genet...

0 0 0 0

Mark D. Garfinkel, Ph.D.

@mdgarfinkel.bsky.social

5 months ago

At the #UAB #SOPH we were teaching our #MPH students about global warming and the real dangers of feedback loops & tipping points TWENTY YEARS AGO.

There is a “they” out there who weren’t listening then… and they’re not listening still.

“…Perhaps they never will.”
— Don McLean, in _Vincent_

5 0 1 0

Bette Midler: Bootleg Betty

@bootlegbetty.bsky.social

5 months ago

Video: Bette Midler: Soph & The Blind Man

#BetteMidler, #BlindMan, #Soph, #SophJokes

bootlegbetty.com/2025/10/23/v...

To Read The Article, Click The Link Above Or Copy/Paste It In Your Browser!

2 1 0 0

StockTitan

@stocktitan.net

5 months ago

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan The companies will also partner to commercialize a liquid biopsy companion diagnostic aimed at advancing personalized and precision cancer care in Japan. As a market leader for genetic testing in Japan with a high-throughput laboratory located in central Tokyo, A.D.A.M. Innovations will continue its legacy of bringing global innovations to Japan by...

#SOPH A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

www.stocktitan.net/news/SOPH/a-d-a-m-innova...

0 0 0 0

StockTitan

@stocktitan.net

5 months ago

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology BOSTON and ROLLE, Switzerland, Oct. 16, 2025/ PRNewswire/-- SOPHiA GENETICS, a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment...

#SOPH SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

www.stocktitan.net/news/SOPH/sop-hi-a-genet...

0 0 0 0

Bityup

@bityup1.bsky.social

6 months ago

Which is your favorite coin? 💯💯🔥🔥🔥🔥👆🔥

#NAKA
#PROPS
#KENDU
#M87
#PEPE
$DOGE
$BNB
$VRA
$SPK
$KAS
$PUMP
#PENGU
#BLOCK
$DARK
$SOL
#ATOM
$BULLA
#CATE
#SOPH

Please comment and support me.

0 0 0 0

StockTitan

@stocktitan.net

6 months ago

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer BOSTON, Sept. 22, 2025/ PRNewswire/-- SOPHiA GENETICS, an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca from the World CB& CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing...

#SOPH #AZN SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

www.stocktitan.net/news/SOPH/sop-hi-a-genet...

0 0 0 0

BitS☀️lar

@sabrialtintas.bsky.social

6 months ago

#Binance #Delist #Altcoins #CryptoNews #SOPH #1000CAT #BNB #CryptoUpdate #Kripto #KriptoHaberleri

0 0 0 0

StockTitan

@stocktitan.net

7 months ago

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology SOPHiA GENETICS (Nasdaq: SOPH) has announced a strategic partnership with Jessa Ziekenhuis, one of Belgium's largest healthcare institutions, to enhance genomic testing and oncology research. The collaboration involves implementing SOPHiA DDM™ platform across Jessa's pathology operations, integrating six specialized applications for various cancer analyses.The partnership aims to achieve significant operational improvements, including 30-50% reduction in hands-on time, up to 25% cost reduction, and faster testing turnaround times. Notably, the collaboration includes a unique arrangement where Jessa Ziekenhuis will share a NovaSeq sequencer with AZ Delta through the Bridge Consortium, optimizing sequencing capacity and knowledge sharing across Belgian healthcare institutions.

#SOPH SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

www.stocktitan.net/news/SOPH/sop-hi-a-genet...

0 0 0 0

BitS☀️lar

@sabrialtintas.bsky.social

7 months ago